Degradation of DRAK1 by CUL3/SPOP E3 Ubiquitin ligase promotes tumor growth of paclitaxel-resistant cervical cancer cells release_h55qnb3jufcrpdkuu2tyafb3am

by Kyoungwha Pang, Jihee Lee, junil kim, Jinah Park, Yuna Park, Eunji Hong, Haein An, Akira Ooshima, Minjung Son, 경순 박, Jae-Hyun Cho, Cheol Lee (+3 others)

Published in Cell Death and Disease by Springer Science and Business Media LLC.

2022   Volume 13, Issue 2, p169

Abstract

<jats:title>Abstract</jats:title>Despite favorable responses to initial chemotherapy, drug resistance is a major cause limiting chemotherapeutic efficacy in many advanced cancers. However, mechanisms that drive drug-specific resistance in chemotherapy for patients with advanced cancers are still unclear. Here, we report a unique role of death-associated protein kinase-related apoptosis-inducing kinase 1 (DRAK1) associated with paclitaxel resistance in cervical cancer cells. Interestingly, DRAK1 protein level was markedly decreased in paclitaxel-resistant cervical cancer cells without affecting its mRNA expression, which resulted in an increase in tumor necrosis factor receptor-associated factor 6 (TRAF6) expression, as well as an activation of TRAF6-mediated nuclear factor-kappa B (NF-κB) signaling cascade, thereby promoting tumor progression. DRAK1 depletion markedly increased the chemotherapeutic IC<jats:sub>50</jats:sub> values of paclitaxel in cervical cancer cells. Ectopic expression of DRAK1 inhibited growth of paclitaxel-resistant cervical cancer cells in vitro and in vivo. Furthermore, DRAK1 was markedly underexpressed in chemoresistant cervical cancer patient tissues compared with chemosensitive samples. We found that DRAK1 protein was destabilized through K48-linked polyubiquitination promoted by the Cullin scaffold protein 3 (CUL3) / speckle-type POZ (poxvirus and zinc finger protein) protein (SPOP) E3 ubiquitin ligase in paclitaxel-resistant cells. Collectively, these findings suggest that DRAK1 may serve as a potential predictive biomarker for overcoming paclitaxel resistance in cervical cancer.
In application/xml+jats format

Archived Files and Locations

application/pdf  4.2 MB
file_d4yeibxzxbg5fjvsaxlbnfmakq
www.nature.com (publisher)
web.archive.org (webarchive)
Read Archived PDF
Preserved and Accessible
Type  article-journal
Stage   published
Date   2022-02-22
Language   en ?
Container Metadata
Open Access Publication
In DOAJ
In ISSN ROAD
In Keepers Registry
ISSN-L:  2041-4889
Work Entity
access all versions, variants, and formats of this works (eg, pre-prints)
Catalog Record
Revision: 1d1557a2-d28e-4c01-a8b5-e34bef6fa64f
API URL: JSON